These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23406797)

  • 1. [Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness].
    Zudaire Bergera JJ; Rincón Mayans A; Rioja Zuazu J; Barba Abad J; Romero Vargas L; Algarra Navarro R; Tienza Fernández A; Robles García JE; Rosell Costa D; Berián Polo JM; Pascual Piédrola JI
    Arch Esp Urol; 2013; 66(1):23-32. PubMed ID: 23406797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in clear cell renal cell carcinoma.
    George S; Bukowski RM
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1737-47. PubMed ID: 18062748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 6. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
    Chen F; Kishida T; Duh FM; Renbaum P; Orcutt ML; Schmidt L; Zbar B
    Cancer Res; 1995 Nov; 55(21):4804-7. PubMed ID: 7585510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers for renal cell carcinoma: impact on diagnosis and treatment.
    Zhou M; Rubin MA
    Semin Urol Oncol; 2001 May; 19(2):80-7. PubMed ID: 11354537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: basic biology and clinical behavior.
    Franklin JR; Figlin R; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease].
    Maroto Rey JP; Cillán Narvaez E
    Arch Esp Urol; 2013 Jun; 66(5):517-23. PubMed ID: 23793769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Traditional and future criteria for progression in renal cell carcinoma. Molecular biology and clinical aspects].
    Pomer S; Staehler G
    Urologe A; 1996 May; 35(3):254-62. PubMed ID: 8711834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of renal cell cancer: pathology and genetics.
    Moch H
    Semin Cancer Biol; 2013 Feb; 23(1):3-9. PubMed ID: 22722066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
    Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
    Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.
    Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM
    J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in Xp11.2 translocation renal cell carcinoma].
    Huang JH; Zhou FJ
    Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.